Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.000
+0.010 (1.01%)
May 7, 2026, 1:45 PM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 2.03 billion as of May 7, 2026. Its market cap has decreased by -15.08% in one year.
Market Cap
2.03B
Enterprise Value
2.73B
Revenue
2.00B
Ranking
n/a
PE Ratio
38.94
Stock Price
1.00
Market Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 2.03B, a decrease of -69.85%. That is a compound annual growth rate of -15.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 2.03B | - |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.11B |
| AIM Vaccine | 2.92B |
| HighTide Therapeutics | 2.30B |
| SinoMab BioScience | 1.96B |
| Mabpharm | 1.86B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.85B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.69B |
| Cutia Therapeutics | 1.67B |